Sorensen Mel
President and CEO at Galera Therapeutics, Inc.
- Sold, on record
- $6k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Nov 20, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Galera Therapeutics, Inc.President and CEO
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice Galera Therapeutics, Inc.NoticeAug 16, 2024 2024
Filed to sell 67,015 shares ($5k)
Sorensen Mel, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale Galera Therapeutics, Inc.No planAug 16, 2024 same day
Sold 67,015 shares at $0.0700 ($5k)
Sorensen Mel, President and CEO
No 10b5-1 planSold 20.2% of holdings ($23k position)265,029 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale Galera Therapeutics, Inc.UnusualNov 20, 2025 +461 days
Sold 70,000 shares at $0.0200 ($1k)
Sorensen Mel, President and CEO
No 10b5-1 planSold 26.4% of holdings ($5k position)195,029 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2025 | Nov 24, 2025 | Galera Therapeutics, Inc. | President and CEO | Form 4 sale | 70,000 | $1k | 26.4% | Unusual | SEC |
| Aug 16, 2024 | Aug 20, 2024 | Galera Therapeutics, Inc. | President and CEO | Form 4 sale | 67,015 | $5k | 20.2% | No plan | SEC |
| Aug 16, 2024 | Aug 16, 2024 | Galera Therapeutics, Inc. | Officer, Director | Form 144 notice | 67,015 | $5k | Notice | SEC |